Computational Drug Discovery (eBook, ePUB)

Methods and Applications
Redaktion: Poongavanam, Vasanthanathan; Ramaswamy, Vijayan

• Format: ePub

Produktbeschreibung

Provide readers with an overview of modern technologies, emphasizing AI for drug discovery. Das E-Book Computational Drug Discovery wird angeboten von Wiley-VCH GmbH und wurde mit folgenden Begriffen kategorisiert: Artificial Intelligence, Arzneimittelforschung, Chemie, Chemistry, Computational Chemistry & Molecular Modeling, Computational Chemistry u. Molecular Modeling, Computer Science, Informatik, Künstliche Intelligenz, Pharmaceutical & Medicinal Chemistry, Pharmazeutische u. Medizinische Chemie, Wirkstoffforschung

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Wiley-VCH
• Seitenzahl: 736
• Erscheinungstermin: 19. Januar 2024
• Englisch
• ISBN-13: 9783527840731
• Artikelnr.: 69861807

Autorenporträt

Vasanthanathan Poongavanam is a senior scientist in the Department of Chemistry-BMC, Uppsala University, Sweden. Before starting at Uppsala University in 2016, he was a postdoctoral fellow at the University of Vienna, Austria, and at the University of Southern Denmark. He obtained his Ph.D. degree in Computational Medicinal Chemistry as a Drug Research Academy (DRA) Fellow at the University of Copenhagen, Denmark, on computational modeling of cytochrome P450. He has published more than 65 scientific articles, including reviews and book chapters. His scientific interests focus on in silico ADMET modeling including cell permeability and solubility, and he has worked extensively on understanding the molecular properties that govern the pharmacokinetic profile of molecules bRo5 property space, including macrocycles and PROTACs. Vijayan Ramaswamy (R.S.K. Vijayan) is a senior research scientist affiliated with the Structural Chemistry division at the Institute for Applied Cancer Science, University of Texas MD Anderson Cancer, TX, USA. In 2016, he joined MD Anderson Cancer after a brief tenure as a scientist, at PMC Advanced Technologies, New Jersey, USA. He undertook postdoctoral training at Rutgers University in New Jersey, USA, and Temple University in Pennsylvania, USA. He received his Ph.D. in Pharmacy as a CSIR senior research fellow from the Indian Institute of Chemical Biology, Kolkata, India. He is a named co-inventor on 7 issued US patents, including an ATR kinase inhibitor that has advanced to Phase 2 clinical trials. He has published more than 20 scientific articles and authored one book chapter. His research focuses on applying computational chemistry methods to drive small molecule drug discovery programs, particularly for oncology and neurodegenerative diseases.

Inhaltsangabe

Preface

Volume 1:

PART I. MOLECULAR DYNAMICS AND RELATED METHODS IN DRUG DISCOVERY
Binding Free Energy Calculations in Drug Discovery
Gaussian Accelerated Molecular Dynamics in Drug Discovery
MD Simulations for Drug-Target (Un)Binding Kinetics
Solvation Thermodynamics and its Competitive Saturation as a Paradigm of Co-Solvent Methods

PART II. QUANTUM MECHANICS APPLICATION FOR DRUG DISCOVERY
QM/MM Approaches for Structure Based Drug Design: Techniques and Applications
Recent Advances in Practical Quantum Mechanics and Mixed-QM/MM Driven X-Ray Crystallography and Cryo-Electron Microscopy (Cryo-EM) and their Impact on Structure-Based Drug Discovery
Quantum-Mechanical Analyses of Interactions for Biochemical Applications

PART III. ARTIFICIAL INTELLIGENCE IN PRE-CLINICAL DRUG DISCOVERY
The Role of Computer Aided Drug Design in Drug Discovery - An Introduction
AI-Based Protein Structure Predictions and their Implications in Drug Discovery
Deep Learning for the Structure-Based Binding Free Energy Prediction of Small Molecule Ligands
Using Artificial Intelligence for the De Novo Drug Design and Retrosynthesis
Reliability and Applicability Assessment for Machine Learning Models

Volume 2:

PART IV. CHEMICAL SPACE AND KNOWLEDGE BASED DRUG DISCOVERY
Enumerable Libraries and Accessible Chemical Space
Navigating Chemical Space
Visualization, Exploration, and Screening of Chemical Space in Drug Discovery
SAR Knowledge Based for Driving Drug Discovery
Cambridge Structural Database (CSD) - Drug Discovery through Data Mining and Knowledge Based Tools

PART V. STRUCTURE-BASED VIRTUAL SCREENING USING DOCKING
Structure-Based Ultra-Large Scale Virtual Screenings
Community Benchmarking Exercises for Docking and Scoring

PART VI. IN SILICO ADMET MODELLING
Advances in the Application of In Silico ADMET Models - An Industry Perspective

PART VII. COMPUTATIONAL APPROACHES FOR NEW THERAPEUTIC MODALITIES
Modelling the Structures of Ternary Complexes Mediated by Molecular Glues
Free Energy Calculations in Covalent Drug Design

PART VIII. COMPUTING TECHNOLOGIES DRIVING DRUG DISCOVERY
Orion® A Cloud-Native Molecular Design Platform
Cloud-Native Rendering Platform and GPUs Aid Drug Discovery
The Quantum Computing Paradigm